ArticleEndocrine, metabolic & immune disorders drug targets2025
Oral Microbiota Associated with Clinical Efficacy of Ustekinumab in Crohn's Disease.
Feiyang Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it